A proteomic approach to the identification of molecular targets in subsequent apoptosis of HEL cells after diosgenin-induced megakaryocytic differentiation

Journal of Cellular Biochemistry

Volumn 107, Issue 4, 2009, Pages 785-796

  Cailleteau, Clementine ^a   Liagre, Bertrand ^a   Beneytout, Jean L ^a  

^a UNIVERSITY OF LIMOGES   (France)

Author keywords

Apoptosis; Differentiation; Diosgenin; Erythroleukemia cells; Kinase; Proteome array

Indexed keywords

CASPASE 8; CASPASE 9; CHECKPOINT KINASE 2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEATH RECEPTOR; DIOSGENIN; PHOSPHOTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; TARGET OF RAPAMYCIN KINASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ERYTHROLEUKEMIA CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; CELL DIFFERENTIATION; CELL LINE, TUMOR; DIOSGENIN; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MEGAKARYOCYTES; PHOSPHOTRANSFERASES; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 67650034288     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22176     Document Type: Article

References (49)

1. Amico D, Barbui AM, Erba E, Rambaldi A, Introna M, Golay J. 2003. Differential response of human acute myeloid leukemia cells to gemtuzumab ozogamicin in vitro: Role of Chk1 and Chk2 phosphorylation and caspase 3. Blood 101:4589-4597. (Pubitemid 36857832)
2. Ashkenazi A. 2002. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2:420-430. (Pubitemid 37328939)
3. Battinelli E, Willoughby SR, Foxall T, Valeri CR, Loscalzo J. 2001. Induction of platelet formation from megakaryocytoid cells by nitric oxide. Proc Natl Acad Sci USA 98:14458-14463. (Pubitemid 33121413)
4. Beneytout JL, Nappez C, Leboutet MJ, Malinvaud G. 1995. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells. Biochem Biophys Res Commun 207:398-404.
5. Braun T, Carvalho G, Grosjean J, Ades L, Fabre C, Boehrer S, Debili N, Fenaux P, Kroemer G. 2007. Differentiating megakaryocytes in myelodysplastic syndromes succumb to mitochondrial derangement without caspase activation. Apoptosis 12:1101-1108. (Pubitemid 46701600)
6. Cailleteau C, Liagre B, Battu S, Jayat-Vignoles C, Beneytout JL. 2008. Increased cyclooxygenase-2 and thromboxane synthase expression is implicated in diosgenin-induced megakaryocytic differentiation in human erythroleukemia cells. Anal Biochem 380:26-34.
7. Cataldi A, di Giacomo V, Rapino M, Genovesi D, Rana RA. 2006. Cyclic nucleotide response element binding protein (CREB) activation promotes survival signal in human K562 erythroleukemia cells exposed to ionising radiation/etoposide combined treatment. J Radiat Res 47:113-120. (Pubitemid 44034029)
8. Chen C, Fuhrken PG, Huang LT, Apostolidis P, Wang M, Paredes CJ, Miller WM, Papoutsakis ET. 2007. A systems-biology analysis of isogenic megakaryocytic and granulocytic cultures identifies new molecular components of megakaryocytic apoptosis. BMC Genomics 8:384.
9. Chiang CT, Way TD, Tsai SJ, Lin JK. 2007. Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation. FEBS Lett 581:5735-5742. (Pubitemid 350235422)
10. Chylicki K, Ehinger M, Svedberg H, Bergh G, Olsson I, Gullberg U. 2000. p53-mediated differentiation of the erythroleukemia cell line K562. Cell Growth Differ 11:315-324. (Pubitemid 30457780)
11. Clarke MC, Savill J, Jones DB, Noble BS, Brown SB. 2003. Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent death. J Cell Biol 160:577-587. (Pubitemid 36254395)
12. Corbiere C, Liagre B, Terro F, Beneytout JL. 2004. Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF), and modulation of caspase-3 activity in different human cancer cells. Cell Res 14:188-196. (Pubitemid 43231816)
13. Creagh EM, Sheehan D, Cotter TG. 2000. Heat shock proteins-modulators of apoptosis in tumour cells. Leukemia 14:1161-1173. (Pubitemid 30445021)
14. Creson TK, Yuan P, Manji HK, Chen G. 2009. Evidence for Involvement of ERK, PI3K, and RSK in Induction of Bcl-2 by Valproate. J Mol Neurosci 37:123-134.
15. De Botton S, Sabri S, Daugas E, Zermati Y, Guidotti JE, Hermine O, Kroemer G, Vainchenker W, Debili N. 2002. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood 100:1310-1317. (Pubitemid 34864286)
16. Duval A, Olaru D, Campos L, Flandrin P, Nadal N, Guyotat D. 2006. Expression and prognostic significance of heat-shock proteins in myelodysplastic syndromes. Haematologica 91:713-714. (Pubitemid 43799480)
17. Frödin M, Gammeltoft S. 1999. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151:65-77. (Pubitemid 29295514)
18. Gordge MP. 2005. Megakaryocyte apoptosis: Sorting out the signals. Br J Pharmacol 145:271-273. (Pubitemid 40896071)
19. Hauge C, Frödin M. 2006. RSK and MSK in MAP kinase signalling. J Cell Sci 119:3021-3023. (Pubitemid 44322115)
20. Higdon K, Scott A, Tucci M, Benghuzzi H, Tsao A, Puckett A, Cason Z, Hughes J. 2001. The use of estrogen, DHEA and diosgenin in a sustained delivery setting as a novel treatment approach for osteoporosis in the ovariectomized adult rat model. Biomed Sci Instrum 37:281-286. (Pubitemid 32381451)
21. Jeanpierre S, Nicolini FE, Kaniewski B, Dumontet C, Rimokh R, Puisieux A, Maguer-Satta V. 2008. BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling. Blood 112:3154-3163.
22. Kim YH, Park C, Lee JO, Kim GY, Lee WH, Choi YH, Ryu CH. 2008. Induction of apoptosis by piceatannol in human leukemic U937 cells through down-regulation of Bcl-2 and activation of caspases. Oncol Rep 19:961-967. (Pubitemid 351802666)
23. Ko LJ, Prives C. 1996. p53: Puzzle and paradigm. Genes Dev 10:1054-1072.
24. Kraus AC, Ferber I, Bachmann SO, Specht H, Wimmel A, Gross MW, Schlegel J, Suske G, Schuermann M. 2002. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways. Oncogene 21:8683-8695.
25. Lannutti BJ, Blake N, Gandhi MJ, Reems JA, Drachman JG. 2005. Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. Blood 105:3875-3878. (Pubitemid 40656131)
26. Lee J, Jung K, Kim YS, Park D. 2007. Diosgenin inhibits melanogenesis through the activation of phosphatidylinositol-3-kinase pathway (PI3K) signaling. Life Sci 81:249-254. (Pubitemid 46992680)
27. Leger DY, Liagre B, Corbiere C, Cook-Moreau J, Beneytout JL. 2004a. Diosgenin induces cell cycle arrest and apoptosis in HEL cells with increase in intracellular calcium level, activation of cPLA2, and COX-2 overexpression. Int J Oncol 25:555-562.
28. Leger DY, Liagre B, Cardot PJ, Beneytout JL, Battu S. 2004b. Diosgenin dose-dependent apoptosis and differentiation induction in human erythroleukemia cell line and sedimentation field-flow fractionation monitoring. Anal Biochem 335:267-278. (Pubitemid 39535192)
29. Leger DY, Liagre B, Beneytout JL. 2006a. Role of MAPKs and NF-kappaB in diosgenin-induced megakaryocytic differentiation and subsequent apoptosis in HEL cells. Int J Oncol 28:201-207.
30. Leger DY, Battu S, Liagre B, Beneytout JL, Cardot PJ. 2006b. Megakaryocyte cell sorting from diosgenin-differentiated human erythroleukemia cells by sedimentation field-flow fractionation. Anal Biochem 355:19-28. (Pubitemid 44041414)
31. Leger DY, Battu S, Liagre B, Cardot PJ, Beneytout JL. 2007. Sedimentation field flow fractionation to study human erythroleukemia cell megakaryocytic differentiation after short period diosgenin induction. J Chromatogr A 1157:309-320. (Pubitemid 46963283)
32. Leszczyniecka M, Roberts T, Dent P, Grant S, Fisher PB. 2001. Differentiation therapy of human cancer: Basic science and clinical applications. Pharmacol Ther 90:105-156. (Pubitemid 32926714)
33. Liagre B, Vergne-Salle P, Corbiere C, Charissoux JL, Beneytout JL. 2004. Diosgenin, a plant steroid, induces apoptosis in human rheumatoid arthritis synoviocytes with cyclooxygenase-2 overexpression. Arthritis Res Ther 6:R373-R383.
34. Liagre B, Leger DY, Vergne-Salle P, Beneytout JL. 2007. MAP kinase subtypes and Akt regulate diosgenin-induced apoptosis of rheumatoid synovial cells in association with COX-2 expression and prostanoid production. Int J Mol Med 19:113-122.
35. Melloni E, Secchiero P, Celeghini C, Campioni D, Grill V, Guidotti L, Zauli G. 2005. Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development. J Cell Physiol 204:975-982. (Pubitemid 41099284)
36. Moalic S, Liagre B, Corbiere C, Bianchi A, Dauca M, Bordji K, Beneytout JL. 2001. A plant steroid, diosgenin, induces apoptosis, cell cycle arrest, and COX activity in osteosarcoma cells. FEBS Lett 506:225-230. (Pubitemid 32964818)
37. Nervi F, Marinovic I, Rigotti A, Ulloa N. 1988. Regulation of biliary cholesterol secretion. Functional relationship between the canalicular and sinusoidal cholesterol secretory pathways in the rat. J Clin Invest 82:1818-1825. (Pubitemid 19054925)
38. Nicholson KM, Anderson NG. 2002. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14:381-395. (Pubitemid 34214843)
39. Nieminen AI, Partanen JI, Klefstrom J. 2007. c-Myc blazing a trail of death: Coupling of the mitochondrial and death receptor apoptosis pathways by c-Myc. Cell Cycle 6:2464-2472. (Pubitemid 350058664)
40. Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW, Adams JM. 1999. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci USA 96:14943-14948. (Pubitemid 30019744)
41. Raju J, Bird RP. 2007. Diosgenin, a naturally occurring furostanol saponin, suppresses 3-hydroxy-3-methylglutaryl CoA reductase expression and induces apoptosis in HCT-116 human colon carcinoma cells. Cancer Lett 255:194-204. (Pubitemid 47268640)
42. Raju J, Mehta R. 2009. Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin. Nutr Cancer 61:27-35.
43. Raju J, Patlolla JM, Swamy MV, Rao CV. 2004. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiol Biomarkers Prev 13:1392-1398. (Pubitemid 39071566)
44. Takagaki K, Katsuma S, Kaminishi Y, Horio T, Tanaka T, Ohgi T, Yano J. 2005. Role of Chk1 and Chk2 in Ara-C-induced differentiation of human leukemia K562 cells. Genes Cells 10:97-106. (Pubitemid 40287513)
45. Vashistha H, Husain M, Kumar D, Yadav A, Arora S, Singhal PC. 2008. HIV-1 expression induces tubular cell G2/M arrest and apoptosis. Ren Fail 30:655-664.
46. Yao CJ, Works K, Romagnoli PA, Austin GE. 2005. Effects of overexpression of HBP1 upon growth and differentiation of leukemic myeloid cells. Leukemia 19:1958-1968. (Pubitemid 41554005)
47. Zauli G, Secchiero P. 2006. The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology. Cytokine Growth Factor Rev 17:245-257. (Pubitemid 44038614)
48. Zeuner A, Signore M, Martinetti D, Bartucci M, Peschle C, De Maria R. 2007. Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor. Cancer Res 67:4767-4773. (Pubitemid 46910184)
49. Zinkel S, Gross A, Yang E. 2006. BCL2 family in DNA damage and cell cycle control. Cell Death Differ 13:1351-1359. (Pubitemid 44057470)